What are the opening hours?

Monday 10:00 - 18:00 Tuesday 10:00 - 18:00 Wednesday 10:00 - 18:00 Thursday 10:00 - 18:00 Friday 10:00 - 18:00

Genomize

Name: Genomize
Address: Boğaziçi Üniversitesi Teknopark No: 303 Rumelihisarı Mahallesi Bebek Yolu Sok. No:2/5, Sarıyer, 34470, TR
Telephone: +902129700688

Home
Turkey
Sarıyer
Genomize

At Genomize, we seek to innovate for health and make these innovations accessible to everybody.

12/12/2023

A new blog article from the Genomize team: “Are Rare Diseases Really Rare?”

🔬 In a world where 'rare' doesn't always mean 'infrequent', our latest article sheds light on the intriguing paradox of rare diseases. While each rare disease might affect a relatively small number of individuals, collectively, they represent a significant health challenge globally. 🌍

💡 Dive into our article to uncover the complexities of rare diseases, the pivotal role of genetic diagnostic tests, and how Genomize integrates Artificial Intelligence (AI) in data analysis to offer quicker and more accurate diagnoses for individuals with rare diseases.

👉 Stay informed, be inspired. To read the full article: https://genomize.com/are-rare-diseases-really-rare/

14/06/2023

Thank you to everyone who joined us at . We appreciate your interest in our variant interpretation software, The SEQ Platform. Your questions and discussions not only enriched the event but helped us better understand your needs and aspirations.�

If we didn't have the chance to meet in Glasgow, we're only a click away! You can schedule an online meeting with our scientists here: https://genomize.com/schedule_demo/

Looking forward to seeing you again in Berlin for !

11/06/2023

Thank you for your interest on Day 1 in our NGS data analysis software, the SEQ Platform!

📍 Visit our booth #244 to experience the new interface of the SEQ Platform and the Variant Prioritization feature. Looking forward to meeting you today!

10/06/2023

Automated ACMG classification of variants is different among different software. Pathogenic becomes VUS, and VUS becomes pathogenic. For a systematic comparison of algorithms with the Clingen truth set, visit our poster at P18.104.D Looking forward to discussing!

09/06/2023

Do you know that you can prioritize the causative variants with a 96.1% prioritization success rate by using the SEQ Platform?

That’s not all! You can also filter the variants by 90% more efficiently with the SEQ Platform’s superior data aggregation and perform CNV Analysis with 95.46% Sensitivity and 99.72% Specificity.

📍 Visit our booth #244 to experience these advantageous features and the new interface of the SEQ Platform. Looking forward to meeting you tomorrow!

26/05/2023

We are ready for !

📍 We welcome all attendees to visit us at booth #244. Our team is excited to demonstrate how the SEQ Platform can serve as a valuable tool for NGS data analysis.

We look forward to your visit and meeting you.

10/05/2023

🙌 Just 1 month to go! We are thrilled about attending ESHG 2023 in Glasgow, 10th-14th June.

🧬 As a dynamic and fast-growing bioinformatics company, we can't wait to showcase our innovative solutions and connect with the brightest minds at .

Are you also attending the ? Let us know in the comments! 💬 And don't forget to tag your colleagues who may be interested in joining us.

13/03/2023

SEQ Platform v7.6 is now live! 🎉

🧬 Support for hg38 Genome Version

You can now align and annotate your samples using the hg38 genome version with the SEQ Platform. Please note that both local and global frequency database tables are separate for hg38 and hg19. You can, however, access hg19 equivalents of hg38 variants easily.

☑ Improved ClinVar Table

ClinVar table design is changed and is now RCV-centric for both hg38 and hg19 annotations.

☑ New Bioinformatic Prediction Tool Scores

Mutpred (hg38 only), MetaRNN (hg38 only), MPC, and VEST4 pathogenicity prediction scores as well as siphy29WayPI (hg38 only) and LINSIGHT (hg38 only) conservation scores are now available.

To try our new features and learn more about the SEQ Platform 👇
https://genomize.com/demo-account-request/

We will have more exciting news very soon. Keep following us!

28/02/2023

Today is , and we want to take a moment to acknowledge people with rare diseases 👇

It's estimated that nearly 300 million people worldwide are affected by one of the 6,000+ different types of rare diseases. Common symptoms of these diseases include difficulty swallowing, muscle weakness, the inability to move or feel parts of the body, vision loss, severe headaches and seizures. Although 72% of rare diseases are inherited genetically, and 70% of these genetic diseases start in childhood, unfortunately, the diagnosis rate is still very low.

As Genomize, we’re committed to supporting individuals with rare diseases by developing innovative solutions that increase diagnosis rates and improve patient outcomes.

We believe that ending rare diseases and raising diagnosis rates require collaboration from all of us!

You can learn more by following the link below;
https://www.rarediseaseday.org/

29/10/2022

29 Ekim Cumhuriyet Bayramımız Kutlu Olsun! 🇹🇷

12/10/2022

SEQ Platform v7.3 is now live! 🎉

👨‍👩‍👧 New Multi-Sample Analysis Interface

"Multi-Sample Analysis", one of the most appreciated and useful features of the SEQ Platform, now has a new interface. With the new interface, you can easily start your duo, trio or cohort comparisons.

In addition to our multi-sample analysis interface, two new pipelines were added for germline analysis:

- v16.10.0: Uses GATK variant caller for variant detection
- v16.11.0: Uses higher sensitivity parameters for FreeBayes variant caller. This pipeline is developed for detection of low fraction variants (

27/10/2021

October marks the breast cancer awareness month. This year we are excited more than ever to show our support because we recently launched our new feature "Somatic Clinical Analysis" within SEQ Platform.

Examining different treatment options, diagnostic/prognostic marker detection and drug resistance detection are essential for deciding the best treatment for cancer patients. As Genomize, we call oncologists around the world to undergo genetic testing for patients to create the roadmaps for their treatment.

Somatic clinical analysis on SEQ Platform offers:

- Small variants calling and annotation with clinical drug databases
- Copy number variations calling
- Fusion detection
- Microsatellite instability calculation
- Tumor mutation burden calculation
- Annotation for protein markers and differential expression

Thanks to the new feature on the SEQ Platform, you can find out treatment options, diagnostic and prognostic markers, and drug resistances by using fully automatic, comprehensive, fast, and reliable somatic clinical analysis. Please follow the link to request a free trial https://genomize.com/demo-account-request/

Address

Boğaziçi Üniversitesi Teknopark No: 303 Rumelihisarı Mahallesi Bebek Yolu Sok. No:2/5
Sarıyer
34470

Opening Hours

Monday	10:00 - 18:00
Tuesday	10:00 - 18:00
Wednesday	10:00 - 18:00
Thursday	10:00 - 18:00
Friday	10:00 - 18:00

Telephone

+902129700688

Website

http://www.genomize.com/

Alerts

Be the first to know and let us send you an email when Genomize posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Genomize:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Business
Claim ownership or report listing

Want your business to be the top-listed Business in Sarıyer?